| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.85 |
1-year : | 1 |
| Resists | First : | 0.73 |
Second : | 0.85 |
| Pivot price | 0.45 |
|||
| Supports | First : | 0.52 |
Second : | 0.38 |
| MAs | MA(5) : | 0.48 |
MA(20) : | 0.45 |
| MA(100) : | 0.44 |
MA(250) : | 0.85 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 50.2 |
D(3) : | 31.2 |
| RSI | RSI(14): 65.5 |
|||
| 52-week | High : | 2.3 | Low : | 0.15 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PSTV ] has closed Bollinger Bands are 22.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.74 - 0.74 | 0.74 - 0.74 |
| Low: | 0.59 - 0.6 | 0.6 - 0.6 |
| Close: | 0.61 - 0.62 | 0.62 - 0.62 |
Fri, 26 Sep 2025
H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Fri, 26 Sep 2025
Plus Therapeutics (PSTV) Stock Rallies as UnitedHealthcare Approves Cancer Test Coverage - parameter.io
Fri, 26 Sep 2025
Plus Therapeutics (PSTV) Soars 40% as Firm Seals Partnership with United Healthcare - Yahoo Finance
Thu, 25 Sep 2025
$PSTV stock is up 32% today. Here's what we see in our data. - Quiver Quantitative
Thu, 25 Sep 2025
Plus Therapeutics (PSTV) Rockets 40% on Major Insurance Win for Cancer Detection Tool – Here's Why Traders Are Buzzing - RagingBull
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 99 (M) |
| Shares Float | 99 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 1.2 (%) |
| Shares Short | 4,660 (K) |
| Shares Short P.Month | 1,860 (K) |
| EPS | -1.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.02 |
| Profit Margin | 0 % |
| Operating Margin | -110.7 % |
| Return on Assets (ttm) | -74.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | -0.03 |
| Sales Per Share | 0.05 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -17 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -0.45 |
| PEG Ratio | 0 |
| Price to Book value | 20.56 |
| Price to Sales | 11.51 |
| Price to Cash Flow | -3.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|